-
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Post on 7/7/19
-
LabShares Newton Selects L Stem Therapeutics as Winner of Second Launch@LabShares Competition Valued at $50K
Post on 7/7/19
-
Blue Cross Blue Shield of Massachusetts Sponsors Free Rides on Bluebikes for 4th of July
Post on 7/7/19
-
T2 Biosystems Reports Granting of Inducement Awards
Post on 7/3/19
-
Bristol-Myers: Otezla Divestiture Highlights Compelling Opportunity
Post on 7/3/19
-
Karuna Therapeutics Closes Initial Public Offering
Post on 7/3/19
-
LogicBio Secures Up To $20 Million Debt Facility
Post on 7/3/19
-
Cybrexa Therapeutics Receives SBIR Grant to Support Development of Lead Candidate CBX-11 in Combination with Chemotherapy Agents
Post on 7/2/19
-
Vertex Pharmaceuticals: A Stock That Continues To Impress In 2019
Post on 7/2/19
-
CVS Health: Trapped Between Growth Expectations And Uncertainty
Post on 7/2/19
-
Morphic Closes Initial Public Offering
Post on 7/2/19
-
Virtua Acquires Lourdes Health System
Post on 7/1/19
-
Miraca and Seventh Sense Biosystems Announce Investment
Post on 7/1/19
-
Bristol-Myers Squibb Completes Divestment of UPSA
Post on 7/1/19
-
3 Top Biotech Stocks to Buy Right Now
Post on 7/1/19
-
ConvenientMD Partners with Health Insurance Companies
Post on 6/30/19
-
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Post on 6/30/19
-
Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Post on 6/30/19
-
T2 Biosystems Named One of the Fastest-Growing Companies in Massachusetts
Post on 6/30/19
-
Peak Physical Therapy & Sports Performance Adds Cynthia Wisted, PT, DPT, at Hanover Clinic
Post on 6/30/19
-
Acer Therapeutics: Despite Receiving A Devastating CRL, The Story Isn't Over
Post on 6/28/19
-
Allena Pharmaceuticals Announces $10.0M Registered Direct Offering of Common Stock
Post on 6/27/19
-
Eutropics Awarded MassVentures Funding to Commercialize Novel Predictive Cancer Diagnostics Technology
Post on 6/27/19
-
Karuna Therapeutics Prices Upsized Initial Public Offering
Post on 6/27/19
-
SpringWorks Therapeutics Announces Global Clinical Collaboration with GlaxoSmithKline
Post on 6/27/19